A detailed history of D. E. Shaw & Co., Inc. transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,745,024 shares of ARQT stock, worth $26.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,745,024
Holding current value
$26.2 Million
% of portfolio
0.02%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.32 - $11.0 $6.14 Million - $8.11 Million
737,640 Added 73.22%
1,745,024 $16.2 Million
Q2 2024

Aug 14, 2024

BUY
$7.24 - $12.53 $5.72 Million - $9.91 Million
790,518 Added 364.52%
1,007,384 $9.37 Million
Q1 2024

May 15, 2024

BUY
$3.25 - $11.77 $704,814 - $2.55 Million
216,866 New
216,866 $2.15 Million
Q1 2023

May 15, 2023

SELL
$10.23 - $17.14 $271,575 - $455,015
-26,547 Reduced 71.41%
10,629 $116,000
Q4 2022

Feb 14, 2023

SELL
$13.96 - $20.4 $519,312 - $758,880
-37,200 Reduced 50.02%
37,176 $550,000
Q3 2022

Nov 14, 2022

BUY
$17.85 - $26.95 $1.33 Million - $2 Million
74,376 New
74,376 $1.42 Million
Q3 2020

Nov 16, 2020

SELL
$23.44 - $32.28 $223,758 - $308,144
-9,546 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$24.48 - $36.56 $233,686 - $349,001
9,546 New
9,546 $289,000

Others Institutions Holding ARQT

About Arcutis Biotherapeutics, Inc.


  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $902M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.